Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5+ DM) is an infrequent autoimmune disease, which mainly distributes in Asians and females. MDA5+ DM usually presents various skin lesions and positive anti-MDA5 antibody (a myositis-specific autoantibody for itsel...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Jinming Yang, Bing Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Subjects:	MDA5 dermatomyositis pneumomediastinum macrophage activation syndrome spontaneous intramuscular hemorrhage
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1009546/full

Similar Items

Anti–Melanoma Differentiation Associated Gene 5 (MDA 5) Dermatomyositis Complicated by Spontaneous Pneumomediastinum: A Case Report From South Africa
by: M. Myburgh
Published: (2024-11-01)

Spontaneous pneumomediastinum and/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system
by: Jiajia Jin, et al.
Published: (2025-10-01)

Case Report: Spontaneous pneumomediastinum in a patient with MDA5-positive dermatomyositis and severe pulmonary fibrosis
by: M. Rizzo, et al.
Published: (2025-10-01)

Spontaneous intramuscular hemorrhage in cancer-associated dermatomyositis: a case and literature review
by: Rui Xing, et al.
Published: (2023-07-01)

Spontaneous pneumomediastinum in dermatomyositis
by: Ankit Jain, et al.
Published: (2017-01-01)

Pneumomediastinum and Pneumopericardium in Rapidly Progressive Interstitial Lung Disease Secondary to Anti‐MDA5 Dermatomyositis
by: Thomas Bond, et al.
Published: (2025-10-01)

Managing a Case of Refractory Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Dermatomyositis with Recent COVID-19 Infection
by: Cheryl Chun Man Ng, et al.
Published: (2023-07-01)

Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis
by: Anusha Vuppala, et al.
Published: (2023-12-01)

Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers
by: Büşra Demirbağ Gül, et al.
Published: (2022-12-01)

Anti-MDA-5 dermatomyositis with tumid lupus-like lesions
by: Kristiana Marie Jordan, BA, et al.
Published: (2025-06-01)

Monocyte–macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis‐related interstitial lung disease
by: Jia Shi, et al.
Published: (2025-02-01)

Fatal recurrence of pneumothorax in an adult dermatomyositis
by: Rakesh Agarwal, et al.
Published: (2015-01-01)

Spontaneous Pneumomediastinum and Subcutaneous Emphysema in Dermatomyositis: A Case Series and Literature Review
by: Subki AH, et al.
Published: (2023-04-01)

Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report
by: Semra Ayduran, et al.
Published: (2024-12-01)

Successful treatment of rapidly progressive interstitial lung disease complicated by a refractory pneumomediastinum in a patient with anti‐MDA5 antibody‐positive dermatomyositis
by: Lili Jiang, et al.
Published: (2023-12-01)

Different antinuclear antibody subgroups of anti-melanoma differentiation-associated gene 5-positive dermatomyositis showed variability in clinical presentation: a multicenter retrospective cohort study
by: Gang Wang, et al.
Published: (2024-10-01)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
by: Anne-Claire Billet, et al.
Published: (2022-12-01)

Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease
by: Yan Li, et al.
Published: (2023-06-01)

Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease
by: Kaikai Zhao, et al.
Published: (2025-02-01)

14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report
by: Mitchell Kinkor, et al.
Published: (2024-09-01)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
by: Yuan Xue, et al.
Published: (2023-01-01)

Clinical features and prognostic factors of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
by: Li Lian, et al.
Published: (2023-06-01)

A less common case of anti‐MDA5 and anti‐Ro52 antibody‐positive juvenile dermatomyositis complicated with macrophage activation syndrome
by: Li Zhang, et al.
Published: (2024-03-01)

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
by: Darija Logvinova, et al.
Published: (2024-11-01)

A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers
by: Sun T, et al.
Published: (2024-01-01)

Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis
by: Tao Liu, et al.
Published: (2022-08-01)

Rare complication spontaneous pneumothorax and pneumomediastinum in COVID-19 patients: A single center experience
by: Türkan Tüzün, et al.
Published: (2023-12-01)

Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil
by: Sumeyye Ozer, MD, et al.
Published: (2024-08-01)

Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study
by: Qiang Ji, et al.
Published: (2023-11-01)

Anti-NXP2 antibody positive dermatomyositis presenting as unilateral heliotrope rash
by: Zeinab F. Saleh, MD, et al.
Published: (2024-08-01)

Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis
by: Chao Sun, et al.
Published: (2025-07-01)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
by: Houari Aissaoui, et al.
Published: (2021-04-01)

Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
by: Xia Lv, et al.
Published: (2022-01-01)

Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort
by: Sai K. Koyoda, et al.
Published: (2025-01-01)

Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis
by: Timmy Strauss, et al.
Published: (2023-09-01)

IDIOPATHIC PNEUMOMEDIASTINUM – CASE REPORT AND REVIEW OF THE LITERATURE
by: Iv. Novakov
Published: (2019-09-01)

Spontaneous Pneumomediastinum in Children
by: Yen-Jhih Liao, et al.
Published: (2021-07-01)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
by: Shuang Zhou, et al.
Published: (2022-08-01)

Dysregulated CD38 expression on T cells was associated with rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 positive dermatomyositis
by: Yixue Guo, et al.
Published: (2024-11-01)

Serum progranulin level is a novel tool for monitoring disease activity of dermatomyositis with antimelanoma differentiation‐associated protein 5 antibodies
by: Asami Fujii, et al.
Published: (2021-06-01)